Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 117–126Cite as

Pulmonary Hypertension and Antiphospholipid Antibodies

  • Chapter

  • 740 Accesses

Keywords

  • Systemic Lupus Erythematosus
  • Pulmonary Embolism
  • Pulmonary Hypertension
  • Systemic Lupus Erythematosus Patient
  • Anticardiolipin Antibody

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gosney JR. Pulmonary hypertension. In: Halliday, Hunt, Poston, Schachter, eds. An introduction to vascular biology. Cambridge: Cambridge University Press; 1998:100–111.

    Google Scholar 

  2. Galie N, Manes A, Uguccioni L, et al. Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest 1998;114(suppl 3):184S–194S.

    PubMed  CAS  Google Scholar 

  3. Haworth SG. Primary pulmonary hypertension. J R Coll Physicians Lond 1998;32:187–190.

    PubMed  CAS  Google Scholar 

  4. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101:927–934.

    CrossRef  PubMed  CAS  Google Scholar 

  5. Mecham RP. Conference summary: biology and pathobiology of the lung circulation. Chest 1998;114(suppl 3):106S–111S.

    PubMed  CAS  Google Scholar 

  6. Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM. Primary pulmonary hypertension between inflammation and cancer. Chest 1998;114(suppl 3):225S–230S.

    PubMed  CAS  Google Scholar 

  7. Fishman AP. Etiology and pathogenesis of primary pulmonary hypertension: a perspective. Chest 1998;114(suppl 3):242S–247S.

    PubMed  CAS  Google Scholar 

  8. Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996;9:356–363.

    CrossRef  PubMed  CAS  Google Scholar 

  9. Cool CD, Rai PR, Yeager ME, et al. Expression of human herpsevirus 8 in primary pulmonary hypertension. N Engl J Med 2003;349:1113–1122.

    CrossRef  PubMed  CAS  Google Scholar 

  10. The International PPH Consortium. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familia primary pulmonary hypertension. Nat Genet 2000;26:81–84.

    CrossRef  CAS  Google Scholar 

  11. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 2003;348:500–509.

    CrossRef  PubMed  CAS  Google Scholar 

  12. Piette JC. 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a “mission impossible”? Lupus 1996;5:354–363.

    PubMed  CAS  Google Scholar 

  13. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994;96:3–9.

    CrossRef  PubMed  CAS  Google Scholar 

  14. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275–286.

    CrossRef  PubMed  CAS  Google Scholar 

  15. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17:1292–1298.

    PubMed  CAS  Google Scholar 

  16. Koike T, Tsutsumi A. Pulmonary hypertension and the antiphospholipid syndrome. Intern Med 1995;34:938.

    PubMed  CAS  Google Scholar 

  17. Kunieda T. Antiphospholipid syndrome and pulmonary hypertension. Intern Med 1996;35:842–843.

    PubMed  CAS  Google Scholar 

  18. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366–374.

    PubMed  CAS  Google Scholar 

  19. Font J, Lopez-Soto A, Cervera R, et al. The “primary” antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991;9:69–75.

    CrossRef  PubMed  CAS  Google Scholar 

  20. Asherson RA, Cervera R, Piette JC, et al. “Catastrophic” antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195–207.

    CrossRef  PubMed  CAS  Google Scholar 

  21. Cervera R, Garcia-Carrasco M, Asherson RA. Pulmonary manifestations in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, eds. The antiphospholipid syndrome. Boca Raton: CRC Press; 1996:161–167.

    Google Scholar 

  22. Mintz G, Acevedo-Vazquez E, Guttierrez-Espinosa G, Avelar-Garnica F. Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Arthritis Rheum 1984;27:539–544.

    PubMed  CAS  Google Scholar 

  23. Brucato A, Baudo F, Barberis M, et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J Rheumatol 1994;21:942–944.

    PubMed  CAS  Google Scholar 

  24. Day SM, Rosenzweig BP, Kronzon I. Transesophageal echocardiographic diagnosis of right atrial thrombi associated with the antiphospholipid syndrome. J Am Soc Echocardiogr 1995;8:937–940.

    CrossRef  PubMed  CAS  Google Scholar 

  25. O’Hickey S, Skinner C, Beattie J. Life-threatening right ventricular thrombosis in association with phospholipid antibodies. Br Heart J 1993;70:279–281.

    PubMed  CAS  Google Scholar 

  26. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997–1002.

    PubMed  CAS  Google Scholar 

  27. Schulman S, Svenungsson E, Granqvist S, and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998;104:332–338.

    CrossRef  PubMed  CAS  Google Scholar 

  28. Kearon C, Gent M, Hirsh J, et al. A Comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901–907.

    CrossRef  PubMed  CAS  Google Scholar 

  29. Anderson NE, Ali MR. The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis 1984;43:760–763.

    PubMed  CAS  Google Scholar 

  30. Sandoval J, Amigo MC, Barragan R, et al. Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy. J Rheumatol 1996;23:772–775.

    PubMed  CAS  Google Scholar 

  31. Ando M, Takamoto S, Okita Y, et al. Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann Thorac Surg 1998;66:1919–1924.

    CrossRef  PubMed  CAS  Google Scholar 

  32. Miyashita Y, Koike H, Misawa A, Shimizu H, Yoshida K, Yasutomi T. Asymptomatic pulmonary hypertension complicated with antiphospholipid syndrome case. Intern Med 1996;35:912–915.

    PubMed  CAS  Google Scholar 

  33. Jeffrey PJ, Asherson RA, Rees PJ. Recurrent deep vein thrombosis, thromboembolic pulmonary hypertension and the “primary” antiphospholipid syndrome. Clin Exp Rheumatol 1989;7:567–569.

    PubMed  CAS  Google Scholar 

  34. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612–617.

    PubMed  CAS  Google Scholar 

  35. Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541–1544.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Cervera R, Khamashta MA, Font J, et al. High prevalence of significant heart valve lesions in patients with the “primary” antiphospholipid syndrome. Lupus 1991;1:43–47.

    PubMed  CAS  Google Scholar 

  37. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579–1587.

    PubMed  CAS  Google Scholar 

  38. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424–1430.

    CrossRef  PubMed  CAS  Google Scholar 

  39. Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997;27:27–35.

    CrossRef  PubMed  CAS  Google Scholar 

  40. Piette JC, Amoura Z, Papo T. Valvular heart disease and systemic lupus erythematosus [letter]. N Engl J Med 1997;336:1324.

    CrossRef  PubMed  CAS  Google Scholar 

  41. Asherson RA, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 1989;73:1103–1115.

    PubMed  CAS  Google Scholar 

  42. Kattwinkel N, Villanueva AG, Labib SB, et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992;116:974–976.

    PubMed  CAS  Google Scholar 

  43. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990;82:369–375.

    PubMed  CAS  Google Scholar 

  44. De Clerck LS, Michielsen PP, Ramael MR, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991;18:1919–1921.

    PubMed  Google Scholar 

  45. Hussein A, Trowitzsch E, Brockmann M. Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent. Klin Padiatr 1999;211:92–95.

    CrossRef  PubMed  CAS  Google Scholar 

  46. Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–2264.

    CrossRef  PubMed  CAS  Google Scholar 

  47. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465–1472.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457–1464.

    CrossRef  PubMed  Google Scholar 

  49. Merkel PA, Chang YC, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576–583.

    CrossRef  PubMed  CAS  Google Scholar 

  50. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999;42:899–909.

    CrossRef  PubMed  CAS  Google Scholar 

  51. Asherson RA, Mackworth-Young CG, Boey ML, et al. Pulmonary hypertension in systemic lupus erythematosus. Br Med J 1983;287:1024–1025.

    CrossRef  CAS  Google Scholar 

  52. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353–365.

    PubMed  CAS  Google Scholar 

  53. Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome. J Rheumatol 1992;19:1778–1781.

    PubMed  CAS  Google Scholar 

  54. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients from a defined population. Medicine (Baltimore) 1992;71:216–223.

    PubMed  CAS  Google Scholar 

  55. Petri M, Rheinschmidt M, Whiting-O’Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med 1987;106:524–531.

    PubMed  CAS  Google Scholar 

  56. Miyata M, Suzuki K, Sakuma F, et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 1993;100:351–354.

    CrossRef  PubMed  CAS  Google Scholar 

  57. Biyajima S, Osada T, Daidoji H, et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjögren’s syndrome. Intern Med 1994;33:768–772.

    PubMed  CAS  Google Scholar 

  58. Tilley S, Newman J, Thomas A. Antiphospholipid and anticentromere antibodies occurring together in a patient with pulmonary hypertension. Tenn Med 1996;89:166–168.

    PubMed  CAS  Google Scholar 

  59. Luchi ME, Asherson RA, Lahita RG. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 1992;35:700–705.

    PubMed  CAS  Google Scholar 

  60. De la Mata J, Gomez-Sanchez MA, Aranzana M, Gomez-Reino JJ. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 1994;37:1528–1533.

    PubMed  Google Scholar 

  61. Nagai H, Yasuma K, Katsuki T, et al. Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report. Angiology 1997;48:183–187.

    PubMed  CAS  Google Scholar 

  62. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 1986;8:1307–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  63. Isern RA, Yaneva M, Weiner E, et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992;93:307–312.

    CrossRef  PubMed  CAS  Google Scholar 

  64. Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol 1998;25:1313–1319.

    PubMed  CAS  Google Scholar 

  65. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000;15:395–399.

    CrossRef  PubMed  CAS  Google Scholar 

  66. Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 1995;99:392–396.

    CrossRef  PubMed  CAS  Google Scholar 

  67. Karmochkine M, Cacoub P, Dorent R, et al. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J Rheumatol 1996;23:286–290.

    PubMed  CAS  Google Scholar 

  68. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  69. Opravil M, Pechere M, Speich R, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 1997;155:990–995.

    PubMed  CAS  Google Scholar 

  70. Cacoub P, Dorent R, Nataf P, et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997;33:196–200.

    CrossRef  PubMed  CAS  Google Scholar 

  71. Atsumi T, Khamashta MA, Haworth RS, et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998;41:800–807.

    CrossRef  PubMed  CAS  Google Scholar 

  72. Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21:2058–2063.

    PubMed  CAS  Google Scholar 

  73. Yoshio T, Masuyama J, Mimori A, Takeda A, Minota S, Kano S. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 1995;54:361–365.

    CrossRef  PubMed  CAS  Google Scholar 

  74. Prandoni P, Lensing A, Büller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327:1128–1133.

    CrossRef  PubMed  CAS  Google Scholar 

  75. Zuckerman E, Toubi E, Golan TD, et al. Increased thromboembolic incidence in anti-cardiolipinpositive patients with malignancy. Br J Cancer 1995;72:447–451.

    PubMed  CAS  Google Scholar 

  76. Ruffatti A, Aversa S, Del Ross T, Tonetto S, Fiorentino M, Todesco S. Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 1994;21:2162–2163.

    PubMed  CAS  Google Scholar 

  77. Papagiannis A, Cooper A, Banks J. Pulmonary embolism and lupus anticoagulant in a woman with renal cell carcinoma. J Urol 1994;152:941–942.

    PubMed  CAS  Google Scholar 

  78. Hibbert M, Braude S. Tumour microembolism presenting as “primary pulmonary hypertension”. Thorax 1997;52:1016–1017.

    CrossRef  PubMed  CAS  Google Scholar 

  79. Piette JC, Cacoub P. Antiphospholipid syndrome in the elderly: caution [editorial]. Circulation 1998;97:2195–2196.

    PubMed  CAS  Google Scholar 

  80. Humbert M, Sanchez O, Fartoukh M, Jagot JL, Sitbon O, Simonneau G. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest 1998;114:80S–82S.

    PubMed  CAS  Google Scholar 

  81. Groen H, Bootsma H, Postma DS, Kallenberg CGM. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol 1993;20:1055–1057.

    PubMed  CAS  Google Scholar 

  82. Tam LS, Li EK. Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome. Lupus 1998;7:495–497.

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Médecine Interne, Groupe Hospitalier Pitié-Salpetrière, Paris, France

    Jean-Charles Piette MD

  2. Department of Clinical Haematology and Rheumatology, London, UK

    Beverley J. Hunt Mb ChB, FRCP, FRCPath, MD

Authors
  1. Jean-Charles Piette MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beverley J. Hunt Mb ChB, FRCP, FRCPath, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Piette, JC., Hunt, B.J. (2006). Pulmonary Hypertension and Antiphospholipid Antibodies. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_11

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation